View
Page
It seems odd to me that when speaking of a possible buyout of Fum as a company that the value of the DermaSys system is never mentioned. Is it really something special? I suspect it must be or why would T&R bother to bring out another TPR gel in a market that is loaded with them now? Could it not be used to deliver other drugs? Seems like a formidable asset unless I am missing something.
Latest from the Community...
Latest from the Community...
Latest from the Community...